Quality of life of 22 patients with type 1 Gaucher disease after enzyme replacement therapy  

作　　者：LI Hongmin 李红敏(Dept Hematol,PUMC Hosp,Beijing 100730)

机构地区：[1]Dept Hematol,PUMC Hosp,Beijing 100730

出　　处：《China Medical Abstracts(Internal Medicine)》2020年第2期71-72,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To investigate the living status and quality of life(QOL)in typel Gaucher disease(GD1)patients who underwent long-term enzyme replacement therapy(ERT)and identify possible relevant factors affecting QOL.Methods Clinical data and SF-36 questionnaires were recorded in 22 adult GD1 patients under regular ERT at Peking Union Medical Colleague Hospital(PUMCH)from January 1995 to June 2017.Results 13 males and 9 females were included in this study.The current median age,age at diagnosis and initial time of ERT were 41(24-52),6(1-38)and 26(6-41)years respectively.

关 键 词：PATIENTS DIAGNOSIS GAUCHER 

分 类 号：R589[医药卫生—内分泌]